Insulin Analog [EPC]

356101 reported adverse events

Drugs of this class: INSULIN ASPART INSULIN LISPRO INSULIN GLARGINE INSULIN DETEMIR INSULIN GLARGINE-YFGN (INSULIN DEGLUDEC AND LIRAGLUTIDE) ATTENTION DEFICIT MILD DROPS ATTENTION DEFICIT SEVERE DROPS DNA INSULIN DROPS INSULIN INSULIN ASPART INJECTION

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 65532
1 DRUG INEFFECTIVE 17363
2 BLOOD GLUCOSE DECREASED 16702
3 NAUSEA 15042
4 HYPOGLYCAEMIA 11617
5 FATIGUE 10666
6 MALAISE 10591
7 DIARRHOEA 10444
8 DYSPNOEA 10438
9 VISUAL IMPAIRMENT 10197
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 1983 0.8406
1 HYPOGLYCAEMIA UNAWARENESS 229 0.7156
2 HYPOGLYCAEMIC UNCONSCIOUSNESS 1162 0.6670
3 HYPOGLYCAEMIC SEIZURE 414 0.5342
4 DIABETIC RETINOPATHY 1336 0.5152
5 SHOCK HYPOGLYCAEMIC 205 0.5049
6 INTERCEPTED PRODUCT SELECTION ERROR 272 0.4936
7 BLOOD GLUCOSE FLUCTUATION 3976 0.4580
8 INSULIN RESISTANCE 650 0.4449
9 BLOOD GLUCOSE INCREASED 65532 0.4383
See all enriched reactions for Insulin Analog [EPC]